ArticleCardio-oncology (London, England)2019

Concomitant use of renin-angiotensin-aldosterone system inhibitors prevent trastuzumab-induced cardiotoxicity in HER2+ breast cancer patients: an institutional retrospective study.

Melissa Y Y Moey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.